{"id":"W4415939879","doi":"10.1016/j.annonc.2025.08.3702","title":"3088P Association of molecular markers with clinical response to TAR-200 in the phase IIb SunRISe-1 trial in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary disease","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Johnson and Johnson; Astellas Pharma; Merck KGaA; Eisai; Else Kröner-Fresenius-Stiftung; AstraZeneca","keywords":"Bladder cancer; Carcinoma in situ; In situ; Carcinoma; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006844994,0.0004920574,0.001081877,0.0002032771,0.0001748687,0.0007606586,0.000333602,0.0007932233,0.003570853],"category_scores_gemma":[0.000727653,0.0002388756,0.0008443909,0.000301108,0.0002368034,0.000411498,0.0002055763,0.001165635,0.0005829008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003445541,"about_ca_system_score_gemma":0.000292352,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003735279,"about_ca_topic_score_gemma":0.0009601534,"domain_scores_codex":[0.9997297,0.0001281748,0.00001880331,0.00004933949,0.00002853166,0.00004543807],"domain_scores_gemma":[0.9996623,0.0001113901,0.00009660574,0.0000185489,0.00002146789,0.00008969437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7056358,0.00334519,0.1238663,0.0009293731,0.003993214,0.0003868632,0.0001171351,0.002700069,0.04452947,0.0004573426,0.005528778,0.1085104],"study_design_scores_gemma":[0.197983,0.157093,0.6045343,0.0003147242,0.007154506,0.001396671,0.0002415963,0.009193469,0.008599333,0.002167125,0.01117823,0.0001439308],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9959532,0.001629061,0.000128967,0.0004180749,0.0001200264,0.00006255011,0.0005186741,0.00003497331,0.001134435],"genre_scores_gemma":[0.9972705,0.0003735503,0.0001916219,0.0002699659,0.00007415029,0.00006637768,0.0007827975,0.000007961353,0.0009631066],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003570853,"threshold_uncertainty_score":0.01194572,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03733582358958509,"score_gpt":0.4027620757087445,"score_spread":0.3654262521191594,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}